Enjoy complimentary customisation on priority with our Enterprise License!
The Global Plethysmograph Market size is estimated to grow by USD 18 million, at a CAGR of 3.2% between 2023 and 2028. The plethysmograph market is experiencing significant growth, driven by several key factors. Firstly, the increasing incidence and prevalence of lung and vascular diseases necessitate the use of advanced diagnostic tools, including plethysmographs. Secondly, there is a high demand for these devices due to their ability to provide accurate and non-invasive measurements of respiratory and peripheral vascular functions. Lastly, increasing awareness about the benefits of early diagnosis and effective treatment of respiratory and vascular conditions is fueling the market growth. Overall, the market is poised for robust expansion in the coming years, driven by these compelling factors.
To learn more about this report, Request Free Sample
In the manufacturing process of medical equipment like lung plethysmographs for assessing lung function, region analysis plays a crucial role. Evaluating pulmonary fibrosis necessitates advanced tools such as body plethysmographs, which require trained personnel to operate due to their complexity and high cost. Raw materials used in these devices are selected meticulously to ensure accuracy and durability, reflecting their critical product position in the medical industry. Moreover, the region analysis helps in understanding geographical trends in diseases like pulmonary fibrosis, aiding healthcare strategies. The evaluation quadrant methodizes data for effective decision-making in healthcare management, and in the adult segment the leveraging insights from lung function tests conducted with precision instruments. As advancements continue in both manufacturing processes and evaluation techniques, the focus remains on enhancing diagnostic capabilities and treatment outcomes for respiratory conditions.
The increasing incidence and prevalence of lung and vascular diseases are notably driving the market growth. Lung and vascular diseases are the leading causes of mortality and morbidity globally. The incidence and prevalence of vascular diseases, such as DVT and pulmonary embolism (blood clots), and lung diseases, such as asthma and COPD, are increasing globally. These diseases are caused due to the abnormal condition of the arterial blood vessel, which can be diagnosed by using plethysmographs. These factors are increasing their applications globally.
The number of people with lung and vascular diseases is increasing, owing to factors such as sedentary lifestyles, obesity, smoking, environmental issues, lack of physical activity, alcohol consumption, and unhealthy eating habits. The increasing incidence of lung and vascular diseases necessitates the need for early diagnosis and regular monitoring of patients for identifying, treating, controlling, and limiting disease incidence and prevalence rates. The availability of advanced diagnostic devices, such as plethysmograph (which screens arterial and venous pathologies by measuring air and blood volume rates), will drive the market during the forecast period.
The advent of next-generation plethysmographs is the key trend in the market. Manufacturers are focusing on the development of next-generation plethysmographs to avoid misinterpretation of test results caused due to the use of conventional plethysmographs. The next-generation plethysmographs come up with the latest hardware design and advanced software features to provide highly accurate results.
For instance, MiniBox plus by PulmOne Advanced Medical Devices is a technologically breakthrough device with the transformation from a body box lung plethysmograph into an accurate tabletop device. It is a desktop, gasless device with complete PFT, such as whole-body plethysmograph, spirometry, and diffusion testing, used in clinical settings. This device is used to measure TLC, residual volume (RV), and single-breath CO diffusion in less than 2 minutes by providing accurate and repeatable results. Similarly, Q-Box by COSMED is a next-generation body box used for thoracic gas volume measurements, including static lung volumes (TLC, RV, and ITGV) and airway resistance and conductance (RAW and GAW) using a body plethysmograph.
Limitations and complications associated with plethysmographs is the major challenge impeding market growth. A plethysmograph is only used to measure the medical condition of a person with lung and vascular diseases, such as the pain in the chest wall and its muscles and the inability of the lungs to expand or contract, causing difficulty in breathing. It is not suitable to determine the cause of lung or vascular disease. Furthermore, the movement of the patient while using a body plethysmograph for the diagnosis of lungs and the presence of compressible material, particularly chairs with foam padding, within the plethysmography chambers cause unpredictable errors in results.
However, one of the complications associated with the use of a plethysmograph is an arterial puncture, which includes thrombosis, artery spasm, bleeding, or hematoma. Furthermore, patients may experience claustrophobia, shortness of breath, anxiety, lightheadedness, and infection risks (infection transmission occurs if the device's mouthpiece is not cleaned properly) while performing the test. All these limitations and complications of plethysmographs are expected to have an adverse impact on the market during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Plethysmograph Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Shanghai TOW Intelligent Technology Co. Ltd. - The company focuses on research, development, and manufacturing of laboratory equipment related to pre-clinical animal and cellular experiments. The company offers plethysmograph namely vivoFlow as its key offering.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of comapanies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize comapanies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize comapanies as dominant, leading, strong, tentative, and weak.
The market share growth of the hospitals segment will be significant during the forecast period. Hospitals are specialized healthcare institutions that offer substantial diagnosis and treatment to patients with acute and complex medical conditions. They have diagnostic centers with expert technicians and sophisticated diagnostic equipment to provide timely, high-quality diagnostic care to patients.
Get a glance at the market contribution of various segments Request a PDF Sample
The hospitals segment was valued at USD 39.80 million in 2018. Hospitals account for a significant share of the global plethysmograph market, owing to factors such as the increasing prevalence of acute and chronic diseases and a rise in the number of highly skilled and experienced pulmonologists. Government initiatives, such as the National Health Mission (NHM), to provide free diagnostic services in hospitals with low-cost and non-invasive devices to improve clinical outcomes in patients are also contributing to the growth of the hospitals segment.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The US is the major revenue contributor to the market in North America, owing to the increasing incidence of lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) and increased research and funding activities. Factors such as the development of next-generation plethysmographs, such as Q-Box by COSMED, will drive the market in the US during the forecast period. Moreover, the presence of key comapanies will also drive the growth of the market in the country.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024 to 2028, as well as historical data from 2018 to 2023 for the following segments.
1. Smart Weight, Body Composition, and Body-Mass Index (BMI) Scales Market: Smart Weight, Body Composition, and Body-Mass Index (BMI) Scales Market Analysis North America, Europe, APAC, South America, Middle East and Africa - US, Canada, China, UK, Germany - Size and Forecast
2. Diagnostic Wearable Medical Devices Market: Diagnostic Wearable Medical Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, China, Japan - Size and Forecast
3. Medical Devices Market: Medical Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, Japan, China, UK - Size and Forecast
In financial analysis of the healthcare sector, understanding revenue data and market insights is crucial for strategic decision-making. Patent analysis informs innovation in diagnosis equipment for respiratory diseases, catering to the geriatric population. Competitor analysis and strategic analysis guide market strategies and expansions, influenced by major collaborations and merger & acquisitions shaping the value chain. Trending innovation drives new developments, impacting business policies and supply-demand gap in the macro market. Geographical analysis identifies secondary drivers impacting supply forces and scenarios for future growth. Historical data provides insights into market trends over the historical period, aiding in the formulation of a robust strategy building model. This holistic approach ensures organizations navigate complexities in the healthcare landscape with informed decisions and sustainable growth strategies.
|
Industry Scope |
|
|
Report Coverage |
Details |
|
Page number |
161 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 3.2% |
|
Market growth 2024-2028 |
USD 18 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
3.03 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 43% |
|
Key countries |
US, China, Germany, Canada, and France |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
ACI Medical LLC, BioTekna Srl, Bonther Equipamentos para Ensino e Pesquisa, COSMED Srl, D. E. Hokanson Inc., Geratherm Medical AG, Medical Electronic Construction, medical equipment Europe GmbH, Medizinische Messtechnik GmbH, MGC Diagnostics Corp., Morgan Scientific Inc., Piston Ltd., PulmOne Advanced Medical Devices Ltd., SCHILLER AG, SCIREQ Scientific Respiratory Equipment Inc., Shanghai TOW Intelligent Technology Co. Ltd., and Vyaire Medical Inc. |
|
Market dynamics |
Parent market analysis, Market forecasting growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.